help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vanderschueren, D.
Right arrow Articles by Ohlsson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanderschueren, D.
Right arrow Articles by Ohlsson, C.
Endocrine Reviews 25 (3): 389-425
Copyright © 2004 by The Endocrine Society

Androgens and Bone

Dirk Vanderschueren, Liesbeth Vandenput, Steven Boonen, Marie K. Lindberg, Roger Bouillon and Claes Ohlsson

Laboratory for Experimental Medicine and Endocrinology (D.V., L.V., S.B., R.B.), and Leuven University Centre for Metabolic Bone Diseases and Division of Geriatric Medicine (S.B.), Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; and Division of Endocrinology, Department of Internal Medicine (M.K.L., C.O.), Sahlgrenska University Hospital, SE-41345 Göteborg, Sweden

Correspondence: Address all correspondence and requests for reprints to: C. Ohlsson, M.D., Ph.D., Division of Endocrinology, Department of Internal Medicine, Sahlgrenska University Hospital, SE-41345 Göteborg, Sweden. E-mail: Claes.Ohlsson{at}medic.gu.se

Loss of estrogens or androgens increases the rate of bone remodeling by removing restraining effects on osteoblastogenesis and osteoclastogenesis, and also causes a focal imbalance between resorption and formation by prolonging the lifespan of osteoclasts and shortening the lifespan of osteoblasts. Conversely, androgens, as well as estrogens, maintain cancellous bone mass and integrity, regardless of age or sex. Although androgens, via the androgen receptor (AR), and estrogens, via the estrogen receptors (ERs), can exert these effects, their relative contribution remains uncertain. Recent studies suggest that androgen action on cancellous bone depends on (local) aromatization of androgens into estrogens. However, at least in rodents, androgen action on cancellous bone can be directly mediated via AR activation, even in the absence of ERs.

Androgens also increase cortical bone size via stimulation of both longitudinal and radial growth. First, androgens, like estrogens, have a biphasic effect on endochondral bone formation: at the start of puberty, sex steroids stimulate endochondral bone formation, whereas they induce epiphyseal closure at the end of puberty. Androgen action on the growth plate is, however, clearly mediated via aromatization in estrogens and interaction with ER{alpha}. Androgens increase radial growth, whereas estrogens decrease periosteal bone formation. This effect of androgens may be important because bone strength in males seems to be determined by relatively higher periosteal bone formation and, therefore, greater bone dimensions, relative to muscle mass at older age. Experiments in mice again suggest that both the AR and ER{alpha} pathways are involved in androgen action on radial bone growth. ERß may mediate growth-limiting effects of estrogens in the female but does not seem to be involved in the regulation of bone size in males.

In conclusion, androgens may protect men against osteoporosis via maintenance of cancellous bone mass and expansion of cortical bone. Such androgen action on bone is mediated by the AR and ER{alpha}.




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
P. Utriainen, J. Jaaskelainen, A. Saarinen, E. Vanninen, O. Makitie, and R. Voutilainen
Body Composition and Bone Mineral Density in Children with Premature Adrenarche and the Association of LRP5 Gene Polymorphisms with Bone Mineral Density
J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4144 - 4151.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
I. Mohamed and J. K Yeh
Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats
J. Endocrinol., August 1, 2009; 202(2): 317 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. K. Baniwal, O. Khalid, D. Sir, G. Buchanan, G. A. Coetzee, and B. Frenkel
Repression of Runx2 by Androgen Receptor (AR) in Osteoblasts and Prostate Cancer Cells: AR Binds Runx2 and Abrogates Its Recruitment to DNA
Mol. Endocrinol., August 1, 2009; 23(8): 1203 - 1214.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
E.S. Orwoll, B.K.S. Chan, L.C. Lambert, L.M. Marshall, C. Lewis, and K.R. Phipps
Sex Steroids, Periodontal Health, and Tooth Loss in Older Men
Journal of Dental Research, August 1, 2009; 88(8): 704 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
C. Ohlsson and L. Vandenput
The role of estrogens for male bone health
Eur. J. Endocrinol., June 1, 2009; 160(6): 883 - 889.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
T. A C M van Geel, P. P Geusens, B. Winkens, J.-P. J E Sels, and G.-J. Dinant
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study
Eur. J. Endocrinol., April 1, 2009; 160(4): 681 - 687.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. L. Eriksson, M. Lorentzon, L. Vandenput, F. Labrie, M. Lindersson, A.-C. Syvanen, E. S. Orwoll, S. R. Cummings, J. M. Zmuda, O. Ljunggren, et al.
Genetic Variations in Sex Steroid-Related Genes as Predictors of Serum Estrogen Levels in Men
J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 1033 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. H. Windahl, N. Andersson, A. S. Chagin, U. E. A. Martensson, H. Carlsten, B. Olde, C. Swanson, S. Moverare-Skrtic, L. Savendahl, M. K. Lagerquist, et al.
The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice
Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E490 - E496.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
U. E. A. Martensson, S. A. Salehi, S. Windahl, M. F. Gomez, K. Sward, J. Daszkiewicz-Nilsson, A. Wendt, N. Andersson, P. Hellstrand, P.-O. Grande, et al.
Deletion of the G Protein-Coupled Receptor 30 Impairs Glucose Tolerance, Reduces Bone Growth, Increases Blood Pressure, and Eliminates Estradiol-Stimulated Insulin Release in Female Mice
Endocrinology, February 1, 2009; 150(2): 687 - 698.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. McRobb, D. J. Handelsman, and A. K. Heather
Androgen-Induced Progression of Arterial Calcification in Apolipoprotein E-Null Mice Is Uncoupled from Plaque Growth and Lipid Levels
Endocrinology, February 1, 2009; 150(2): 841 - 848.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. Callewaert, K. Venken, J. Ophoff, K. De Gendt, A. Torcasio, G. H. van Lenthe, H. Van Oosterwyck, S. Boonen, R. Bouillon, G. Verhoeven, et al.
Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-{alpha}
FASEB J, January 1, 2009; 23(1): 232 - 240.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. E. Stevenson, B. A. J. Evans, E. F. Gevers, C. Elford, R. W. J. McLeod, M. J. Perry, M. M. El-Kasti, K. T. Coschigano, J. J. Kopchick, S. L. Evans, et al.
Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency?
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E147 - E156.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
H.-Y. Kang, C.-R. Shyr, C.-K. Huang, M.-Y. Tsai, H. Orimo, P.-C. Lin, C. Chang, and K.-E. Huang
Altered TNSALP Expression and Phosphate Regulation Contribute to Reduced Mineralization in Mice Lacking Androgen Receptor
Mol. Cell. Biol., December 15, 2008; 28(24): 7354 - 7367.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. F. Yarrow, C. F. Conover, A. V. Purandare, A. M. Bhakta, N. Zheng, B. Conrad, M. K. Altman, S. E. Franz, T. J. Wronski, and S. E. Borst
Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1213 - E1222.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
K. Venken, R. Bouillon, and D. Vanderschueren
Androgens Versus Estrogens: Different Theories About Opposing Actions on Periosteal Bone Expansion
IBMS BoneKEy, April 1, 2008; 5(4): 130 - 136.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. H. Windahl, M. K. Lagerquist, N. Andersson, C. Jochems, A. Kallkopf, C. Hakansson, J. Inzunza, J.-A. Gustafsson, P. T. van der Saag, H. Carlsten, et al.
Identification of Target Cells for the Genomic Effects of Estrogens in Bone
Endocrinology, December 1, 2007; 148(12): 5688 - 5695.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
J. E. Aubin, R. Bouillon, T. A. Guise, and I. R. Reid
Meeting Report from the 17th Scientific Meeting of the International Bone and Mineral Society: June 24-29, 2007 in Montreal, Quebec, Canada
IBMS BoneKEy, November 1, 2007; 4(11): 299 - 313.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
H. V. Heemers, K. M. Regan, S. M. Dehm, and D. J. Tindall
Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer
Cancer Res., November 1, 2007; 67(21): 10592 - 10599.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Swanson, M. Lorentzon, L. Vandenput, F. Labrie, A. Rane, J. Jakobsson, S. Chouinard, A. Belanger, and C. Ohlsson
Sex Steroid Levels and Cortical Bone Size in Young Men Are Associated with a Uridine Diphosphate Glucuronosyltransferase 2B7 Polymorphism (H268Y)
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3697 - 3704.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
M. J. Walton, N. Kumar, D. T. Baird, H. Ludlow, and R. A. Anderson
7{alpha}-Methyl-19-Nortestosterone (MENT) vs Testosterone in Combination With Etonogestrel Implants for Spermatogenic Suppression in Healthy Men
J Androl, September 1, 2007; 28(5): 679 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X.-H. Liu, A. Kirschenbaum, S. Yao, G. Liu, S. A. Aaronson, and A. C. Levine
Androgen-Induced Wnt Signaling in Preosteoblasts Promotes the Growth of MDA-PCa-2b Human Prostate Cancer Cells
Cancer Res., June 15, 2007; 67(12): 5747 - 5753.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Grundberg, K. Akesson, A. Kindmark, P. Gerdhem, A. Holmberg, D. Mellstrom, O. Ljunggren, E. Orwoll, H. Mallmin, C. Ohlsson, et al.
The Impact of Estradiol on Bone Mineral Density Is Modulated by the Specific Estrogen Receptor-{alpha} Cofactor Retinoblastoma-Interacting Zinc Finger Protein-1 Insertion/Deletion Polymorphism
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2300 - 2306.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
J.-P. Bonjour and T. Chevalley
Pubertal Timing, Peak Bone Mass and Fragility Fracture Risk
IBMS BoneKEy, February 1, 2007; 4(2): 30 - 48.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Hirbe, E. A. Morgan, O. Uluckan, and K. Weilbaecher
Skeletal complications of breast cancer therapies.
Clin. Cancer Res., October 15, 2006; 12(20): 6309s - 6314s.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Leger, D. Marinovic, C. Alberti, S. Dorgeret, D. Chevenne, C. L. Marchal, N. Tubiana-Rufi, G. Sebag, and P. Czernichow
Lower Bone Mineral Content in Children with Type 1 Diabetes Mellitus Is Linked to Female Sex, Low Insulin-Like Growth Factor Type I Levels, and High Insulin Requirement
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3947 - 3953.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Sobel, B. Schwartz, Y.-S. Zhu, J. J. Cordero, and J. Imperato-McGinley
Bone Mineral Density in the Complete Androgen Insensitivity and 5{alpha}-Reductase-2 Deficiency Syndromes
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3017 - 3023.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. J. Tracz, K. Sideras, E. R. Bolona, R. M. Haddad, C. C. Kennedy, M. V. Uraga, S. M. Caples, P. J. Erwin, and V. M. Montori
Testosterone Use in Men and Its Effects on Bone Health. A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2011 - 2016.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. A. Sims, K. Brennan, J. Spaliviero, D. J. Handelsman, and M. J. Seibel
Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E456 - E462.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
V Rochira, A Balestrieri, B Madeo, L Zirilli, A R M Granata, and C Carani
Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology
Eur. J. Endocrinol., February 1, 2006; 154(2): 175 - 185.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Vanderschueren, K. Venken, J. Ophoff, R. Bouillon, and S. Boonen
Sex Steroids and the Periosteum--Reconsidering the Roles of Androgens and Estrogens in Periosteal Expansion
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 378 - 382.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
K. Venken and D. Vanderschueren
Dual Mode of Action of Androgens on the Skeleton: Are Androgen Receptor and Estrogen Receptor Activation Equally Important at the Same Time and Place?
IBMS BoneKEy, January 1, 2006; 3(1): 15 - 17.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Q. Wang, M. Alen, P. H. F. Nicholson, J. M. Halleen, S. L. Alatalo, C. Ohlsson, H. Suominen, and S. Cheng
Differential Effects of Sex Hormones on Peri- and Endocortical Bone Surfaces in Pubertal Girls
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 277 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
V. E. MacRae, C. Farquharson, and S. F. Ahmed
The pathophysiology of the growth plate in juvenile idiopathic arthritis
Rheumatology, January 1, 2006; 45(1): 11 - 19.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
N. Andersson, U. Islander, E. Egecioglu, E. Lof, C. Swanson, S. Moverare-Skrtic, K. Sjogren, M. K Lindberg, H. Carlsten, and C. Ohlsson
Investigation of central versus peripheral effects of estradiol in ovariectomized mice
J. Endocrinol., November 1, 2005; 187(2): 303 - 309.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. N. Zhuang, L. P. Ly, R. G. Cumming, and D. J. Handelsman
Growth and Development during Early Manhood as Determinants of Prostate Size in Later Life
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6055 - 6063.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul
Transforming Growth Factor-{beta}1 to the Bone
Endocr. Rev., October 1, 2005; 26(6): 743 - 774.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. Aminorroaya, S. Kelleher, A. J Conway, L. P Ly, and D. J Handelsman
Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men
Eur. J. Endocrinol., June 1, 2005; 152(6): 881 - 886.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
J. Chen, J. Kim, and J. T. Dalton
Discovery and Therapeutic Promise of Selective Androgen Receptor Modulators
Mol. Interv., June 1, 2005; 5(3): 173 - 188.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. J. Warden, A. G. Robling, M. S. Sanders, M. M. Bliziotes, and C. H. Turner
Inhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth
Endocrinology, February 1, 2005; 146(2): 685 - 693.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Bouillon, M. Bex, D. Vanderschueren, and S. Boonen
Estrogens Are Essential for Male Pubertal Periosteal Bone Expansion
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6025 - 6029.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
E. Seeman and G. J. Strewler
Clinical and Basic Research Papers - May and June 2004 Selections
IBMS BoneKEy, July 1, 2004; 1(7): 1 - 3.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society